对基于粒子的多分析技术和用于抗脂自身抗体测试的商业ELISA的诊断性能进行比较评估

Abdulrahman Saadalla1, Camille L Novis2, Dipanwita Banerjee2

  • 1ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.

概括

基于粒子的多分析技术 (PMAT) 显示出对诊断抗脂综合征 (APS) 的前景,在检测抗脂 (aPL) 抗体,特别是IgA同型时,其灵敏度与ELISA相比或更高.